Page last updated: 2024-08-17

prednisone and imiquimod

prednisone has been researched along with imiquimod in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beyeler, M; Dummer, R1
Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W1
Brunetti, G; Cozzi, R; Lo Schiavo, A; Puca, RV; Ruocco, E; Sangiuliano, S1
Bianchi, L; Campione, E; Chimenti, S; Citarella, L; Del Principe, I; Di Prete, M; Diluvio, L; Orlandi, A1
Sayama, K; Shiraishi, K1

Reviews

1 review(s) available for prednisone and imiquimod

ArticleYear
[Standard and experimental therapy of cutaneous T-cell lymphoma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:12

    Topics: Adrenal Cortex Hormones; Aminoquinolines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell; Methotrexate; Photopheresis; Prednisone; PUVA Therapy; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Recombinant Proteins; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vincristine

2003

Other Studies

4 other study(ies) available for prednisone and imiquimod

ArticleYear
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:10

    Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine

2003
Contact pemphigus: a side-effect of imiquimod therapy.
    International journal of dermatology, 2008, Volume: 47, Issue:7

    Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescent Antibody Technique, Direct; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Methylprednisolone; Middle Aged; Papillomaviridae; Papillomavirus Infections; Pemphigus; Prednisone; Risk Assessment; Treatment Outcome; Vulvar Diseases

2008
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports.
    Journal of medical case reports, 2016, Mar-11, Volume: 10

    Topics: Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Imiquimod; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Treatment Outcome; Vincristine

2016
Pemphigus foliaceus induced by topical imiquimod treatment.
    International journal of dermatology, 2018, Volume: 57, Issue:12

    Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Complement C3; Humans; Imiquimod; Immunoglobulin G; Keratosis, Actinic; Male; Middle Aged; Pemphigus; Prednisone; Treatment Outcome

2018